Bayer SeedGrowth™ succeeds with launch of ILeVO™ and acquisition of Biagro Laboratories
With the U.S. launch of ILeVO, a highly effective seed treatment product, Bayer has again demonstrated its innovative capabilities. ILeVO is the only product tackling the soybeans Sudden Death Syndrome (SDS) and nematodes including soybean cyst nematode, one of the most yield-robbing pests in soybeans. "This is another innovation that complements our great offer in soybeans and our nematode control portfolio, which already includes CropStar™ in Latin America, Poncho™/VOTIVO™ and Aeris™ in the USA", said Martin Gruss, Global Head of SeedGrowth at Bayer.
To expand its product range in biological seed treatments, Bayer acquired in 2014 Biagro Group, a South American company with expertise in seed-applied inoculants. With the acquisition, Bayer has strengthened its integrated offer for soybeans in Argentina and Brazil. "Two years later, Biagro is now fully integrated into our company. Combined with the expertise in our laboratories for biological crop protection in West Sacramento, USA, and Wismar, Germany, we strive to further enhance our SeedGrowth portfolio for soybeans and become an important business partner for soybean growers", Gruss said. Highly targeted in their application, seed-applied biologicals aim to improve yields and quality for farmers growing crops such as soybeans, while minimizing exposure to non-target components of the environment.
At the congress, Bayer SeedGrowth™ showcased innovative solutions in all of its four areas of competence, which range from new seed treatment products and improved film coatings which increase the flowability of treated seeds to on-demand seed treatment equipment and quality assessments, as well as customer advice and services.
Get to know more about Bayer SeedGrowth on http://www.seedgrowth.bayer.com/
